mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0003 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
0.18 |
0.0003 |
mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0004 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |